Nexlizet Interactions
There are 110 drugs known to interact with Nexlizet (bempedoic acid/ezetimibe), along with 5 disease interactions. Of the total drug interactions, 31 are major, 75 are moderate, and 4 are minor.
- View all 110 medications that may interact with Nexlizet
- View Nexlizet disease interactions (5)
Most frequently checked interactions
View interaction reports for Nexlizet (bempedoic acid/ezetimibe) and the medicines listed below.
- allopurinol
- amlodipine
- aspirin
- Aspirin Low Strength (aspirin)
- atorvastatin
- Benadryl (diphenhydramine)
- carvedilol
- clopidogrel
- CoQ10 (ubiquinone)
- Eliquis (apixaban)
- ezetimibe
- famotidine
- gabapentin
- hydrochlorothiazide
- Jardiance (empagliflozin)
- levothyroxine
- lisinopril
- losartan
- metformin
- Metoprolol Succinate ER (metoprolol)
- montelukast
- omeprazole
- Ozempic (semaglutide)
- pantoprazole
- prednisone
- Repatha (evolocumab)
- rosuvastatin
- spironolactone
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
Nexlizet disease interactions
There are 5 disease interactions with Nexlizet (bempedoic acid/ezetimibe) which include:
Report options
QR code containing a link to this page
More about Nexlizet (bempedoic acid/ezetimibe)
- Nexlizet consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (14)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: antihyperlipidemic combinations
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
